The enterohepatic circulation

Bile is synthesized in hepatocytes from cholesterol via a multi-step enzymatic pathway whose rate-limiting enzyme is cholesterol 7α-hydroxylase (CYP7A1). The synthesized bile acids — predominantly cholic acid and chenodeoxycholic acid in their primary forms — are conjugated with glycine or taurine to improve water solubility, transported into bile canaliculi, concentrated in the gallbladder, and released into the duodenum during meals through cholecystokinin-mediated gallbladder contraction.

In the duodenum and small intestine, bile acids serve as detergents — emulsifying dietary fat into small micelles that pancreatic lipase can act on. They also activate FXR and TGR5 nuclear receptors, producing signaling effects on glucose metabolism, microbiome composition, and intestinal barrier function. These signaling effects are increasingly recognized as central to metabolic health, beyond the simple emulsification role.

After their work in the small intestine, most bile acids are reabsorbed in the terminal ileum through specific transporters (the apical sodium-dependent bile acid transporter, ASBT). The reabsorbed bile acids return to the liver via the portal vein, are taken up by hepatocytes, re-secreted into bile, and recycled. This is the enterohepatic circulation. Each bile acid molecule may cycle through this loop dozens of times in its lifetime.

A small fraction — approximately 5 percent of the daily bile acid pool — escapes reabsorption and is excreted in stool. This 5 percent represents the body's net cholesterol export each day. The liver synthesizes new bile acids to replace what was lost, drawing carbon and ring structure from circulating cholesterol. This is the cholesterol clearance mechanism that diet, exercise, statins, fibrates, and bile acid sequestrants all variously target.

Soluble fiber as a bile acid sequestrant

Soluble fibers — particularly psyllium husk, but also glucomannan, oat β-glucan, pectin, and others — bind bile acids in the intestinal lumen, reducing their availability for ASBT-mediated reabsorption in the terminal ileum. The bound bile acids are excreted in stool. The body, sensing reduced bile acid return, upregulates CYP7A1 and synthesizes more bile acids from cholesterol, drawing down circulating LDL.

This mechanism is the dominant cholesterol-lowering effect of dietary fiber. It is well-characterized, dose-dependent, and produces measurable LDL reduction at sustained intakes of 10 to 25 grams of soluble fiber per day. The effect is small in absolute terms (typical LDL reductions of 5 to 10 percent at standard supplementation doses) but is essentially additive to other cholesterol-lowering interventions, well-tolerated long-term, and free of the side effects that pharmaceutical bile acid sequestrants can produce.

The Riverclear protocol's evening psyllium dose of 5 to 10 grams is calibrated for this effect. Higher doses produce larger fractional bile acid binding but also produce GI bulk that becomes problematic. Lower doses are inadequate to produce measurable LDL effect. The 5 to 10 gram range is the operational sweet spot.

Why bile flow matters for fat loss

Cholesterol-derived lipids are not the only metabolic exports that move through bile. The bile pathway is also the primary clearance route for cholesterol-derived steroid metabolites, certain fat-soluble toxins, fat-soluble drug metabolites, and the broader category of compounds that the liver processes through Phase II conjugation. When bile flow is sluggish, all of these exports back up.

Sluggish bile flow is a defining feature of the damp-phlegm phenotype. It produces post-meal heaviness (insufficient bile for lipid emulsification), fatty food intolerance, sluggish bowel (bile is a colonic motility signal), and over time, hepatic steatosis (the liver retains lipids it cannot export). The TCM frame describes this as liver qi stagnation; the Western frame describes it as functional cholestasis or NAFLD/MASLD. The two pictures describe the same physiology.

Restoring bile flow produces broad downstream benefits beyond cholesterol clearance. Hepatic Phase II detoxification capacity improves. Microbiome composition shifts favorably (bile acid signaling at TGR5 affects intestinal barrier function and microbial ecology). Fat-soluble nutrient absorption improves. Post-meal energy improves because the liver is no longer congested with material it cannot move.

The Drain stack architecture

The Drain window addresses the bile axis through three independent inputs:

TUDCA (tauroursodeoxycholic acid) is a hydrophilic bile acid that improves bile flow at the canalicular membrane and protects hepatocytes from the toxicity of more hydrophobic bile acids. It is, in effect, an exogenous bile acid that shifts the overall bile composition toward a more fluid, less stagnant state.

Milk thistle (silymarin) supports hepatocyte membrane integrity and Phase II conjugation pathways. Its effect on bile flow is indirect — by maintaining hepatocyte function and supporting glutathione synthesis, it improves the hepatocyte's capacity to perform bile acid synthesis and secretion.

Magnesium citrate relaxes the smooth muscle of the sphincter of Oddi and biliary tree, improving the mechanical aspect of bile flow into the duodenum. The relaxation also supports the broader parasympathetic shift that the evening Drain window initiates.

Bao He Wan and Jue Ming Zi (TCM) provide additional gentle descending and liver-clearing action that aligns with the bile axis support.

Together with the psyllium, these compounds simultaneously restore bile flow, force bile acid loss to feces, and clear the daily metabolic burden through the bowel. The system operates as a coherent evening evacuation rather than a collection of separate interventions.

Pre-meal bile mobilization

The Dissolve window also addresses the bile axis, but through a different mechanism. Bitter compounds — gentian, dandelion, artichoke in the digestive bitters formula — trigger CCK release through bitter taste receptors on the tongue and gut, causing pre-meal gallbladder contraction. Bile that has been mobilized into the duodenum before the meal arrives produces more efficient lipid emulsification than bile mobilized only in response to arriving fat.

This pre-meal mobilization is the daytime complement to the evening flow restoration. The two windows together — pre-meal mobilization in Dissolve, flow restoration and acid sequestration in Drain — produce sustained bile axis improvement that single-window interventions do not match.

Contraindications

Biliary obstruction is an absolute contraindication for any bile-axis intervention. Users with diagnosed gallstones should have imaging confirmation that the stones are not at risk of obstructing the cystic or common bile ducts before adding TUDCA, ox bile, or aggressive choleretic compounds. Users with cholecystectomy (gallbladder removed) generally tolerate the protocol well and often benefit substantially, but should monitor for any new symptoms of bile-related discomfort.

Inflammatory bowel disease, particularly Crohn's disease affecting the terminal ileum, alters bile acid recirculation in ways that can interact with psyllium and TUDCA in unpredictable ways. Users with IBD should consult their gastroenterologist before adding the Drain stack.

Related